Nurdan Gül

663 total citations
43 papers, 232 citations indexed

About

Nurdan Gül is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Nurdan Gül has authored 43 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 7 papers in Genetics. Recurrent topics in Nurdan Gül's work include Pituitary Gland Disorders and Treatments (11 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Nurdan Gül is often cited by papers focused on Pituitary Gland Disorders and Treatments (11 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Nurdan Gül collaborates with scholars based in Türkiye, Hungary and Germany. Nurdan Gül's co-authors include Ayşe Kubat Üzüm, S Molvalílar, İlhan Satman, N Özbey, Alp Bozbora, Sevgi Kalayoğlu Beşışık, E Sencer, Refik Tanakol, Ferihan Aral and Sevim Purısa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Nurdan Gül

32 papers receiving 224 citations

Peers

Nurdan Gül
Alberto Ragni Italy
Svetlana Zorić Serbia
Ana Devesa Spain
Lia Gutiérrez United States
Alexander Dreval United States
Kiyoe Kurahashi Japan
C Augeri Italy
Irene Weiss United States
H.A.P. Pols Netherlands
M. Ventura Italy
Alberto Ragni Italy
Nurdan Gül
Citations per year, relative to Nurdan Gül Nurdan Gül (= 1×) peers Alberto Ragni

Countries citing papers authored by Nurdan Gül

Since Specialization
Citations

This map shows the geographic impact of Nurdan Gül's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nurdan Gül with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nurdan Gül more than expected).

Fields of papers citing papers by Nurdan Gül

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nurdan Gül. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nurdan Gül. The network helps show where Nurdan Gül may publish in the future.

Co-authorship network of co-authors of Nurdan Gül

This figure shows the co-authorship network connecting the top 25 collaborators of Nurdan Gül. A scholar is included among the top collaborators of Nurdan Gül based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nurdan Gül. Nurdan Gül is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çaklılı, Özge Telci, Nurdan Gül, Ayşe Kubat Üzüm, et al.. (2025). Clinical Characteristics and Development of Complications Differ Between Adult‐Onset and Child–Adolescent‐Onset Type 1 Diabetes: A Report From a Tertiary Medical Center in Türkiye. Journal of Diabetes Research. 2025(1). 8860118–8860118.
2.
3.
4.
5.
Gül, Nurdan, et al.. (2024). Characteristics of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A. SHILAP Revista de lepidopterología. 34(3). 92–96. 1 indexed citations
6.
Işık, Emine Göknur, Duygu Has Şimşek, Nurdan Gül, et al.. (2024). Head-to-Head Comparison of 68Ga-FAPI-04 and 68Ga-DOTA-TATE PET/CT in Recurrent Medullary Thyroid Cancer. Clinical Nuclear Medicine. 50(2). e80–e86. 2 indexed citations
7.
Yılmaz, Hülya, Nurdan Gül, Şükran Poyrazoğlu, et al.. (2024). Target gene variations of PPAR isoforms may contribute to MODY heterogeneity: A preliminary comparative study with type 2 diabetes. Diabetes Research and Clinical Practice. 218. 111932–111932.
8.
Doğanşen, Sema Çiftçi, Zeliha Hekimsoy, Şenay Topsakal, et al.. (2024). Comparison of clinical, hormonal, pathological and treatment outcomes of ectopic Cushing’s syndrome by sex: results of a multicenter study. Endocrine. 86(3). 1148–1155. 1 indexed citations
9.
Liu, Jiahua, Jingfang Zhou, Yanfei Ren, et al.. (2024). Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction. BMC Cardiovascular Disorders. 24(1). 691–691. 3 indexed citations
10.
Gül, Nurdan, et al.. (2024). The effect of COVID-19 pandemic on new-onset adult diabetes and its one-year follow-up. Primary care diabetes. 19(1). 74–81.
11.
Yeğen, Gülçin, Semen Önder, Nurdan Gül, et al.. (2023). Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer. Endocrine. 82(2). 353–360. 1 indexed citations
12.
Tanrıkulu, Seher, Bilge Bılgıç, Emine Göknur Işık, et al.. (2023). Diagnosis and management of tumor-induced osteomalacia: a single center experience. Endocrine. 82(2). 427–434. 4 indexed citations
13.
Sulu, Cem, Nurdan Gül, Seher Tanrıkulu, et al.. (2023). Risk of impulse control disorders in patients with Cushing’s disease: do not blame cabergoline but do not give up caution. Pituitary. 26(4). 495–509. 2 indexed citations
14.
Demir, Semra, et al.. (2023). The first successful desensitization protocol in exenatide allergy: a case report. Allergy Asthma and Clinical Immunology. 19(1). 2–2. 7 indexed citations
15.
Gül, Nurdan, et al.. (2022). Cytokine Profile in Patients With Maturity-onset Diabetes of the Young (MODY). In Vivo. 36(5). 2490–2504. 2 indexed citations
16.
Yılmaz, Özlem, et al.. (2021). WHAT ARE THE FACTORS AFFECTING THE FRAILTY OF ELDERLY PEOPLE WITH TYPE 2 DIABETES?. SHILAP Revista de lepidopterología. 84(1). 1–8.
17.
18.
Tanrıkulu, Seher, et al.. (2017). Utility of baseline serum phosphorus levels for predicting remission in acromegaly patients. Journal of Endocrinological Investigation. 40(8). 867–874. 7 indexed citations
19.
Çelik, Selda, et al.. (2015). Utility of DN4 questionnaire in assessment of neuropathic pain and its clinical correlations in Turkish patients with diabetes mellitus. Primary care diabetes. 10(4). 259–264. 27 indexed citations
20.
Özbey, N, Sevgi Kalayoğlu Beşışık, Nurdan Gül, et al.. (2004). Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated. International Journal of Clinical Practice. 58(6). 554–558. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Ragni Breakdown of academic impact, for papers by Svetlana Zorić Breakdown of academic impact, for papers by Ana Devesa Breakdown of academic impact, for papers by Lia Gutiérrez Breakdown of academic impact, for papers by Alexander Dreval Breakdown of academic impact, for papers by Kiyoe Kurahashi Breakdown of academic impact, for papers by C Augeri Breakdown of academic impact, for papers by Irene Weiss Breakdown of academic impact, for papers by H.A.P. Pols Breakdown of academic impact, for papers by M. Ventura
Rankless by CCL
2026